OAK BROOK, Ill.--(BUSINESS WIRE)--July 7, 2006--Bio-Bridge Science, Inc. (OTCBB:BGES - News) a developer of vaccines with broad preventative and therapeutic applications, is pleased to announce that the Company will be presenting at the 2006 C.E. Unterberg Towbin Emerging Growth Conference, July 11-12, at The Mandarin Oriental Hotel in New York. The presentation, to be given by Dr. Liang Qiao, the Company’s Chairman and CEO, is scheduled for Wednesday, July 12 at 3:56 pm (ET). Dr. Liang Qiao will provide a company overview as well as in-depth information regarding the recently completed pre-clinical trials of its Oral HIV Vaccine.
